Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Yong Cui Image

      Yong Cui, PhD

      Department of Behavioral Science, Division of Cancer Prevention and Population Sciences

      About Dr. Yong Cui

      I study psychophysiology, including ERP and facial EMG, related to the affective, attentional, and inhibitory processes impacted by nicotine dependence and withdrawal. In addition to my research interest in identifying cognitive and affective mechanisms in smoking and its intervention, I am also interested in leveraging novel technologies, particularly smartphone apps, to develop non-pharmacological treatments for nicotine dependence. Complementing conventional pharmacotherapies, these mobile interventions can potentially improve smokers' capability of quitting smoking. I have also pursued research in the tobacco regulatory science, particularly in the domain of electronic cigarettes.


      Read More

      Present Title & Affiliation

      Primary Appointment

      Assistant Professor, The University of Texas MD Anderson Cancer Center, Houston, TX

      Dual/Joint/Adjunct Appointment

      Assistant Professor, The University of Texas MD Anderson Cancer Center, Houston, TX

      Education & Training

      Degree-Granting Education

      2012Translational Biology & Molecular Medicine, Baylor College of Medicine, Houston, Texas, US, Translational Addiction Research, Ph.D
      2007School of Life Sciences, Fudan University, Shanghai, CN, Biological Sciences, BS

      Postgraduate Training

      2012-2017Research Fellowship, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Experience & Service

      Faculty Academic Appointments

      Instructor, Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - 2020

      Honors & Awards

      2012Halliburton Employees Postdoctoral Fellowship in Cancer Prevention Research, Cancer Prevention Research & Training Program, MD Anderson Cancer Center
      2010Poster Winner, Trainee Research Day, MD Anderson Cancer Center
      2006Excellent Group Member of the Undergraduate Association of Fudan University, Fudan University
      2004People’s Scholarship, Fudan University
      2004Team Leader Awarded of the Best Ten Social Practical Projects of Undergraduates, Shanghai University

      Professional Memberships

      Society for Psychophysiological Research

      2010 - Present

      Society for Research on Nicotine and Tobacco

      2010 - Present

      American Psychological Association

      2010 - Present

      Selected Presentations & Talks

      National Presentations

      1. 2015. Error processing in daily smokers: The influence of individual differences in behavioral inhibition and activation sensitivity and smoking abstinence. Invited. Poster Presentation. Seattle, WA, US.
      2. 2014. The Influence of Personality Traits on Nicotine Treatment Outcome. Invited. American Psychological Association. Washington, DC, US.
      3. 2012. Alpha oscillations in response to affective and cigarette-related stimuli in smokers. Invited. Poster Presentation. Houston, TX, US.
      4. 2011. The impact of nicotine dependence severity and depression vulnerability on the responses to unpleasant stimuli in smokers. Invited. Poster Presentation. Boston, MA, US.
      5. 2010. Differential startle cue reactivity in light and heavy smokers. Invited. Poster Presentation. Portland, OR, US.

      International Presentations

      1. 2017. The impact of nicotine dose and dose expectancy on automatic evaluations of cigarette stimuli. Society for Research on Nicotine and Tobacco-Europe. Invited. Society for Research on Nicotine and Tobacco-Europe. Florence, IT.
      2. 2015. Do former smokers still find cigarette-related stimuli to be motivationally salient?. Conference. World Conference on Tobacco or Health. Abu Dhabi, AE.
      3. 2014. ERP Measures of Attentional Bias to Affective and Smoking Cue Distracters are Sensitive to Smoking and Smoking Expectancy. Invited. Society for Research on Nicotine and Tobacco-Europe. Santiago de Compostela, ES.
      4. 2013. Effects of smoking cessation treatment with varenicline, bupropion, or placebo on subjective tonic craving and ERPs to cigarette-related, emotional, and neutral images. Invited. The 53rd annual meeting of the Society of Psychophysiological Research. Florence, IT.
      5. 2013. The impact of anticipated dose and nicotine dose on attentional distraction in overnight-deprived smokers. Invited. The 53rd annual meeting of the Society of Psychophysiological Research. Florence, IT.
      6. 2012. The effect of nicotine availability on performance during a vigilance task with affective and smoking cue distracters. Invited. Society for Research on Nicotine and Tobacco-Europe. Helsinki, FI.

      Formal Peers

      1. 2015. The 55st Annual Meeting of the Society of Psychophysiological Research. Invited. Seattle, WA, US.
      2. 2012. The 18th Annual Meeting of the Society for Research on Nicotine and Tobacco. Invited. Houston, TX, US.
      3. 2011. The 51st Annual Meeting of the Society of Psychophysiological Research. Invited. Boston, MA, US.
      4. 2011. The Trainee Research Day. Invited. Houston, TX, US.
      5. 2011. The 50th Annual Meeting of the Society of Psychophysiological Research. Invited. Portland, OR, US.
      6. 2011. Student Seminar, Program in Translational Biology & Molecular Medicine. Invited. Houston, TX, US.
      7. 2010. Student Seminar, Program in Translational Biology & Molecular Medicine. Invited. Houston, TX, US.
      8. 2010. The 20th Rush & Helen Record Neuroscience Forum. Invited. Woodlands, TX, US.
      9. 2010. The Trainee Research Day. Invited. Houston, TX, US.
      Read More
      Less

      Grant & Contract Support

      Date: 2024 - 2026
      Title:Dyadic yoga Program for Patients with Lung Cancer Undergoing Radiotherapy and their Family Caregivers
      Funding Source:National Institutes of Health
      Role:Co-I
      ID:4R37CA231522-07
      Date: 2024 - 2029
      Title:Supporting Tobacco-Related Ongoing Education and Research (STRONGER) Scholar Program
      Funding Source:NIH/NCI
      Role:Mentor
      ID:1R25DA059907-01
      Date: 2024 - 2028
      Title:Comparative Effectiveness of Sequential Pharmacotherapeutic Strategies and Virtually Delivered Treatment to Optimize Smoking Cessation
      Funding Source:National Institutes of Health/ National Cancer Institute
      Role:Co-I
      ID:1R01CA278938-01A1
      Date: 2023 - 2028
      Title:Penn State TCORS: Tobacco Product Composition Effects on Toxicity and Addiction, Project 3: Randomized placebo-controlled trial of nicotine pouches in smokers
      Funding Source:NIH/NIDA
      Role:Co-I
      ID:U54DA058271

      Selected Publications

      Peer-Reviewed Articles

      1. Robinson, JD, Anthenelli, RM, Cinciripini, PM, Karam-Hage, M, Cui, Y, Kypriotakis, G, Ait-Daoud Tiouririne, N. High- and low-dose topiramate for the treatment of persons with alcohol use disorder who smoke cigarettes. Alcohol, Clinical and Experimental Research 49(12):2865-2874, 2025. e-Pub 2025. PMID: 41220371.
      2. Cinciripini, PM, Minnix, JA, Kypriotakis, G, Erasmus, JJ, Beneventi, DM, Karam-Hage, M, Carpenter, K, Volk, R, Carter, B, Godoy, M, Strange, CD, Shih, YT, Cui, Y, Green, CE, Robinson, JD. Smoking Cessation Interventions in the Lung Cancer Screening Setting. JAMA Internal Medicine 185(3):284-291, 2025. e-Pub 2025. PMID: 39804633.
      3. Robinson, JD, Cui, Y, Karam-Hage, M, Blalock, J, Shete, S, Kypriotakis, G, Yang, P, Cinciripini, PM. Standardized research electronic cigarette acceptability among adult men and women who smoke combustible cigarettes. Psychology of Addictive Behaviors 39(8):780-791, 2025. e-Pub 2025. PMID: 41051837.
      4. Cinciripini, PM, Wetter, DW, Wang, J, Yu, R, Kypriotakis, G, Kumar, T, Robinson, JD, Cui, Y, Green, CE, Bergen, AW, Kosten, TR, Scherer, S, Shete, S. Deep sequencing of candidate genes identified 14 variants associated with smoking abstinence in an ethnically diverse sample. Scientific reports 14(1), 2024. e-Pub 2024. PMID: 38493193.
      5. Robinson, JD, Cui, Y, Kypriotakis, G, Engelmann, JM, Karam-Hage, M, Minnix, JA, Green, CE, Shete, S, Hatsukami, D, Donny, EC, Murphy, SE, Hecht, SS, Eissenberg, T, Wetter, DW, Cinciripini, PM. Evaluating the Human Abuse Potential of Concurrent Use of Electronic Cigarettes and Low Nicotine Cigarettes Among Adults Who Smoke. Experimental and clinical psychopharmacology 33(2):133-144, 2024. e-Pub 2024. PMID: 39541521.
      6. Robinson, JD, Cui, Y, Engelmann, JM, Kypriotakis, G, Cinciripini, PM. Using Eye Tracking to Evaluate the Impact of Smartphone-Delivered Attentional Bias Modification Training for Smokers. Experimental and clinical psychopharmacology 32(6):728-736, 2024. e-Pub 2024. PMID: 38934914.
      7. Cinciripini, PM, Green, CE, Shete, S, Minnix, JA, Robinson, JD, Cui, Y, Kim, S, Kypriotakis, G, Beneventi, DM, Blalock, J, Versace, F, Karam-Hage, M. Smoking Cessation After Initial Treatment Failure With Varenicline or Nicotine Replacement. JAMA 331(20):1722-1731, 2024. e-Pub 2024. PMID: 38696203.
      8. Robinson, JD, Kypriotakis, G, Karam-Hage, M, Cui, Y, Beneventi, DM, Blalock, J, Minnix, JA, Cinciripini, PM. Brief report. American Journal on Addictions 33(3):339-342, 2024. e-Pub 2024. PMID: 37807121.
      9. Kypriotakis, G, Kim, S, Karam-Hage, M, Robinson, JD, Minnix, JA, Blalock, J, Cui, Y, Beneventi, DM, Kim, B, Pan, IE, Shih, YT, Cinciripini, PM. Examining the Association between Abstinence from Smoking and Healthcare Costs among Patients with Cancer. Cancer Prevention Research 17(5):217-225, 2024. e-Pub 2024. PMID: 37940143.
      10. Cui, Y, Robinson, JD, Kypriotakis, G, Minnix, JA, Green, CE, Kim, S, Karam-Hage, M, Cinciripini, PM. Comparable Cigarette Consumption Data Collected Using Timeline Follow-Back and Digital Diary Among Treatment-Seeking Smokers. Psychology of Addictive Behaviors 38(3):315-322, 2023. e-Pub 2023. PMID: 37747518.
      11. Cinciripini, PM, Minnix, JA, Robinson, JD, Kypriotakis, G, Cui, Y, Blalock, J, Lam, CY, Wetter, DW. The Effects of Scheduled Smoking Reduction and Precessation Nicotine Replacement Therapy on Smoking Cessation. JMIR Formative Research 7, 2023. e-Pub 2023. PMID: 37338956.
      12. Robinson JD, Karam-Hage M, Kypriotakis G, Beneventi D, Blalock JA, Cui Y, Gonzalez R, Tayar J, Chaftari P, Cinciripini PM. Bupropion XL and SR have similar effectiveness and adverse event profiles when used to treat smoking among patients at a comprehensive cancer center. Am J Addict 3(3):236-241, 2022. e-Pub 2022. PMID: 35347796.
      13. Robinson JD, Cui Y, Karam-Hage M, Kypriotakis G, Versace F, Ait-Daoud Tiouririne N, Anthenelli RM, Cinciripini PM. Topiramate decreases the salience of motivationally relevant visual cues among smokers who abuse alcohol. Alcohol Clin Exp Res 46(3):384-395, 2022. e-Pub 2022. PMID: 35037278.
      14. Robinson JD, Cui Y, Linares Abrego P, Engelmann JM, Prokhorov AV, Vidrine DJ, Shete S, Cinciripini PM. Sustained reduction of attentional bias to smoking cues by smartphone-delivered attentional bias modification training for smokers. Psychol Addict Behav 36(7):906-919, 2022. e-Pub 2022. PMID: 35025555.
      15. Cui Y, Robinson JD, Rymer RE, Minnix JA, Cinciripini PM. You don't need an app – Conducting mobile smoking research using a Qualtrics-based approach. Front Digit Health 3(799468), 2022. e-Pub 2022. PMID: 35072.
      16. Cui Y, Robinson JD, Rymer RE, Minnix JA, Cinciripini PM. Python Package abstcal: An Open-Source Tool for Calculating Abstinence from Timeline Followback Data. Nicotine Tob Res 24(1):146-148, 2022. e-Pub 2022. PMID: 33912971.
      17. Cui Y, Robinson JD, Rymer RE, Minnix JA, Cinciripini PM. You Don't Need an App-Conducting Mobile Smoking Research Using a Qualtrics-Based Approach. Front Digit Health 3:799468, 2021. e-Pub 2021. PMID: 35072151.
      18. Cui Y, Linares Abrego P, Yoon JH, Karam-Hage M, Cinciripini PM, Ait-Daoud Tiouririne N, Anthenelli RM, Robinson JD. Behavioral Economic Assessment of Alcohol and Cigarette Demand in Smokers with Alcohol Use Disorder. Front Psychiatry 12:674607, 2021. e-Pub 2021. PMID: 34248711.
      19. Cui Y, Engelmann JM, Gilbert DG, Waters AJ, Cinciripini PM, Robinson JD. The impact of nicotine dose and instructed dose on smokers' implicit attitudes to smoking cues: An ERP study. Psychol Addict Behav 33(8):710-720, 2019. e-Pub 2019. PMID: 31657594.
      20. Versace F, Stevens EM, Robinson JD, Cui Y, Deweese MM, Engelmann JM, Green CE, Karam-Hage M, Lam CY, Minnix JA, Wetter DW, Cinciripini PM. Brain Responses to Cigarette-Related and Emotional Images in Smokers During Smoking Cessation: No Effect of Varenicline or Bupropion on the Late Positive Potential. Nicotine Tob Res 21(2):234-240, 2019. e-Pub 2019. PMID: 29220524.
      21. Cui Y, Engelmann JM, Xian J, Minnix JA, Lam CY, Karam-Hage M, Cinciripini PM, Robinson JD. Pharmacological intervention and abstinence in smokers undergoing cessation treatment: A psychophysiological study. Int J Psychophysiol 123:25-34, 2018. e-Pub 2018. PMID: 29223599.
      22. Robinson JD, Versace F, Engelmann JM, Cui Y, Gilbert DG, Waters AJ, Gritz ER, Cinciripini PM. Attentional bias to smoking and other motivationally relevant cues is affected by nicotine exposure and dose expectancy. J Psychopharmacol 30(7):627-40, 2016. e-Pub 2016. PMID: 27097731.
      23. Cui Y, Tang R, Lam CY, Cinciripini PM, Robinson JD. The influence of personality traits on smokers' affect, withdrawal and cessation intervention outcome. Addict Behav 54:7-11, 2016. e-Pub 2016. PMID: 26656672.
      24. Cui Y, Robinson JD, Engelmann JM, Lam CY, Minnix JA, Karam-Hage M, Wetter DW, Dani JA, Kosten TR, Cinciripini PM. Reinforcement sensitivity underlying treatment-seeking smokers' affect, smoking reinforcement motives, and affective responses. Psychol Addict Behav 29(2):300-11, 2015. e-Pub 2015. PMID: 25621416.
      25. Robinson JD, Versace F, Engelmann JM, Cui Y, Slapin A, Oum R, Cinciripini PM. The motivational salience of cigarette-related stimuli among former, never, and current smokers. Exp Clin Psychopharmacol 23(1):37-48, 2015. e-Pub 2015. PMID: 25436840.
      26. Robinson JD, Engelmann JM, Cui Y, Versace F, Waters AJ, Gilbert DG, Gritz ER, Cinciripini PM. The effects of nicotine dose expectancy and motivationally relevant distracters on vigilance. Psychol Addict Behav 28(3):752-60, 2014. e-Pub 2014. PMID: 24841184.
      27. Minnix JA, Versace F, Robinson JD, Lam CY, Engelmann JM, Cui Y, Brown VL, Cinciripini PM. The late positive potential (LPP) in response to varying types of emotional and cigarette stimuli in smokers: a content comparison. Int J Psychophysiol 89(1):18-25, 2013. e-Pub 2013. PMID: 23643564.
      28. Cui Y, Versace F, Engelmann JM, Minnix JA, Robinson JD, Lam CY, Karam-Hage M, Brown VL, Wetter DW, Dani JA, Kosten TR, Cinciripini PM. Alpha oscillations in response to affective and cigarette-related stimuli in smokers. Nicotine Tob Res 15(5):917-24, 2013. e-Pub 2013. PMID: 23060019.
      29. Robinson JD, Versace F, Lam CY, Minnix JA, Engelmann JM, Cui Y, Karam-Hage M, Shete SS, Tomlinson GE, Chen TT, Wetter DW, Green CE, Cinciripini PM. The CHRNA3 rs578776 Variant is Associated with an Intrinsic Reward Sensitivity Deficit in Smokers. Front Psychiatry 4:114, 2013. e-Pub 2013. PMID: 24065931.
      30. Cui Y, Robinson JD, Versace F, Lam CY, Minnix JA, Karam-Hage M, Dani JA, Kosten TR, Wetter DW, Brown VL, Cinciripini PM. Differential cigarette-related startle cue reactivity among light, moderate, and heavy smokers. Addict Behav 37(8):885-9, 2012. e-Pub 2012. PMID: 22571920.
      31. Lam CY, Robinson JD, Versace F, Minnix JA, Cui Y, Carter BL, Wetter DW, Cinciripini PM. Affective reactivity during smoking cessation of never-quitters as compared with that of abstainers, relapsers, and continuing smokers. Exp Clin Psychopharmacol 20(2):139-50, 2012. e-Pub 2012. PMID: 22039752.
      32. Engelmann JM, Versace F, Robinson JD, Minnix JA, Lam CY, Cui Y, Brown VL, Cinciripini PM. Neural substrates of smoking cue reactivity: a meta-analysis of fMRI studies. Neuroimage 60(1):252-62, 2012. e-Pub 2012. PMID: 22206965.
      33. Robinson JD, Lam CY, Carter BL, Minnix JA, Cui Y, Versace F, Wetter DW, Cinciripini PM. A multimodal approach to assessing the impact of nicotine dependence, nicotine abstinence, and craving on negative affect in smokers. Exp Clin Psychopharmacol 19(1):40-52, 2011. e-Pub 2011. PMID: 21341922.
      34. Pontiggia P, Rizzo S, Cuppone-Curto F, Sabato A, Rotella G, Silvotti MG, Martano F. Higher survival of refractory metastatizing breast cancer after thermotherapy and autologous specific antitumoral immunotherapy. Anticancer Res 16(5B):3071-4, 1996. e-Pub 1996. PMID: 8920769.
      35. Ling WH, Jones PJ. Enhanced efficacy of sitostanol-containing versus sitostanol-free phytosterol mixtures in altering lipoprotein cholesterol levels and synthesis in rats. Atherosclerosis 118(2):319-31, 1995. e-Pub 1995. PMID: 8770325.
      36. Cui Y, Robinson JD, Kypriotakis G, Minnix JA, Green CE, Kim S, Cinciripini PM. Comparable cigarette consumption data collected using timeline follow-back and digital diary among treatment-seeking smokers. Psychology of Addictive Behaviors.
      37. Robinson JD, Kypriotakis G, Karam-Hage M, Cui Y, Beneventi D, Blalock JA, CinciripinipP. Characterization of Electronic cigarette use among patients of a comprehensive cancer center. JAMA.
      38. Robinson, J D, Cui, Y, Engelmann, J M, Kypriotakis, G, Cinciripini, P M. Using eye tracking to evaluate the impact of smartphone-delivered attentional bias modification training for smokers. Exp Clin Psychopharmacol. Experimental & Clinical Psychopharmacology.
      39. Kypriotakis G, Kim S, Karam-Hage M, Robinson JD, Minnix JA, Blalock JA, Cui Y, Beneventi D, Kim B, I-W P, Y-CT S, Cinciripini PM. Examining the Association between Abstinence from Smoking and Healthcare Costs Among Patients with Cancer. Cancer Prevention Research.

      Review Articles

      1. Robinson JD, Cui Y, Kypriotakis G, Engelmann JM, Karam-Hage, Minnix JA, Green CE, Shete S, Hatsukami DK, Donny EC, Murphy SE, Hecht SS, Eissenberg T, Wetter DW, Cinciripini PM. Evaluating the abuse liability of concurrent use of electronic cigarettes and low nicotine cigarettes among adults who smoke. Exp Clin Psychopharmacol. e-Pub 2024.

      Abstracts

      1. Cui Y, Robinson JD, Green CE, Minnix JA, Karam-Hage M, Cinciripini PM. Utilization and reliability of smartphone-enabled carbon monoxide devices in a remote smoking cessation trial. Annual Meeting of the Society for Research on Nicotine and Tobacco, 2022. e-Pub 2022.
      2. Cui Y, Abrego P, Engelmann JM, Prokhorov AV, Vidrine DJ, Versace F, Cinciripini PM, Robinson JD. The effects of smartphone-delivered attentional bias modification training on smokers’ attention to smoking cues. Annual Meeting of the Society for Research on Nicotine and Tobacco, 2020. e-Pub 2020.
      3. Abrego P, Cui Y, Engelmann JM, Prokhorov AV, Vidrine DJ, Versace F, Cinciripini PM, Robinson JD. Can brain reactivity to smoking cues predict abstinence? A replication analysis. Annual Meeting of the Society for Research on Nicotine and Tobacco, 2020. e-Pub 2020.
      4. Versace F, Green CE, Deweese M, Robinson JD, Cui Y, Kypriotakis G, Karam-Hage M, Minnix JA, Blalock JA, Frank D, Cinciripini PM. Using a neuroaffective biomarker to match smokers to either varenicline or nicotine patch treatment. Annual Meeting of the Society for Research on Nicotine and Tobacco, 2019. e-Pub 2019.
      5. Sacks RL, Cui Y, Karam-Hage M. Impact of smoking cessation in locally advanced head and neck cancers undergoing radiation. Journal of Clinical Oncology, no. 15_suppl,:6068-6068, 2019. e-Pub 2019.
      6. Linares Abrego P, Cui Y, Cinciripini PM, Tiouririne NA, Anthenelli R, Karam-Hage M, Yoon J, Robinson JD. Nicotine dependence, but no alcohol dependence, is associated with increased demand in the purchase task among alcohol-abusing smokers. Annual Meeting of the Society for Research on Nicotine and Tobacco, 2019. e-Pub 2019.
      7. Kareem S, Kypriotakis G, Beneventi DM, Blalock J, Minnix JA, Robinson JD, Cui Y, Cinciripini PM. Real-time audio-video versus in-person evaluation and treatment planning for smoking cessation treatment. Annual Meeting of the American Academy of Addiction Psychiatry, 2018. e-Pub 2018.
      8. Robinson JD, Engelmann JM, Cui Y, Versace F, Gilbert DG, Waters AJ, Gritz ER, Cinciripini PM. The impact of nicotine dose and dose expectancy on automatic evaluations of cigarette stimuli. Society for Research on Nicotine and Tobacco-Europe, Florence, Italy, 2017. e-Pub 2017.
      9. Robinson JD, Versace F, Engelmann JM, Cui Y, Slapin A, Oum R, Cinciripini PM. Do former smokers still find cigarette-related stimuli to be motivationally salient?. World Conference on Tobacco or Health, Abu Dhabi, United Arab Emirates, 2015. e-Pub 2015.
      10. Cui Y, Robinson JD. Error processing in daily smokers: The influence of individual differences in behavioral inhibition and activation sensitivity and smoking abstinence. The 55th annual meeting of the Society of Psychophysiological Research, Seattle, Washington, 2015. e-Pub 2015.
      11. Robinson JD, Versace F, Engelmann JM, Cui Y, Gilbert DG, Waters AJ, Gritz ER, Cinciripini PM. ERP Measures of Attentional Bias to Affective and Smoking Cue Distracters are Sensitive to Smoking and Smoking Expectancy. Society for Research on Nicotine and Tobacco-Europe, Santiago de Compostela, Spain, 2014. e-Pub 2014.
      12. Tang R, Cui Y, Robinson JD, Cinciripini PM. The Influence of Personality Traits on Nicotine Treatment Outcome. American Psychological Association, Washington, DC, 2014. e-Pub 2014.
      13. Robinson JD, Versace F, Cui Y, Engelmann JF, Gilbert DG, Waters AJ, Gritz ER, Cinciripini PM. The impact of anticipated dose and nicotine dose on attentional distraction in overnight-deprived smokers. The 53rd annual meeting of the Society of Psychophysiological Research, Florence, Italy, 2013. e-Pub 2013.
      14. Versace F, Robinson JD, Green CE, Slapin A, Cui Y, Ng J, Engelmann JM, Karam-Hage M, Minnix JA, Lam CY, Wetter DW, Cinciripini PM. Effects of smoking cessation treatment with varenicline, bupropion, or placebo on subjective tonic craving and ERPs to cigarette-related, emotional, and neutral images. The 53rd annual meeting of the Society of Psychophysiological Research, Florence, Italy, 2013. e-Pub 2013.
      15. Robinson JD, Engelmann JE, Cui Y, Versace F, Waters AJ, Gilbert DG, Gritz ER, Cinciripini PM. The effect of nicotine availability on performance during a vigilance task with affective and smoking cue distracters. Society for Research on Nicotine and Tobacco-Europe, Helsinki, Finland, 2012. e-Pub 2012.
      16. Cui Y, Versace F, Engelmann JM, Minnix JA, Robinson JD, Lam CY, Karam-Hage M, Brown VL, Wetter DW, Dani JA, Kosten TR, Cinciripini PM. Alpha oscillations in response to affective and cigarette-related stimuli in smokers. The Society for Research on Nicotine and Tobacco Annual Meeting, Houston, Texas, 2012. e-Pub 2012.
      17. Cui, Y, Robinson JD, Versace F, Lam CY, Minnix JA, Dani JA, Kosten TR, Wetter DW, Brown VL, Cinciripini PM. The impact of nicotine dependence severity and depression vulnerability on the responses to unpleasant stimuli in smokers. The 51st annual meeting of the Society of Psychophysiological Research, Boston, Massachusetts, 2011. e-Pub 2011.
      18. Cui, Y, Robinson, JD, Versace, F, Lam, CY, Minnix, JA, Dani, JA, Cinciripini, PM. Differential startle cue reactivity in light and heavy smokers. The 50th annual meeting of the Society of Psychophysiological Research, Portland, Oregon, 2010. e-Pub 2010.
      Read More
      Less

      Patient Reviews


      CV information above last modified July 22, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top